I was at the IIME conference yesterday and Dr Peterson gave a rapid talk in which he updated us on all the ME studies that are ongoing in the US at the moment. He started by describing a study looking for XMRV, although he did not introduce it as "the Lipkin study" so I only realised this must be what he was refering to after he had moved on to the next topic. It seemed quite a small study, the patients and controls carefully matched, and the samples were spread among three labs, one of which was named "the Mikovits lab in New York". This study is completed and the results will be released on the 30th June, and he said it "should draw a line under XMRV" and from the tone of his voice it sounds as if he knows the result to be negative. He then moved on to describe another study looking for pathogens, and this was when Lipkin's name was mentioned for the first time, and I realised that the first study must be what we refer to as the Lipkin study. I cannot be certain of the exact details as I was too unwell to take notes at the time. I initially thought I would be too ill to go, and only changed my mind at the last minute and had to miss the first part of the conference as a result.